Human Data Increases Pledge of PeopleBio Shares, Raising Potential Dilution and Governance Risks

Human Data and its related parties have provided an additional 3,865,759 PeopleBio shares as collateral, increasing the total pledged shares to 19,007,457.
This pledge is aimed at securing loans for Human Data, unrelated to PeopleBio's capital needs, thereby increasing the financial burden on the largest shareholder.
A significant portion of shares is now pledged, posing risks of stock price decline and potential equity dilution if loan defaults trigger collateral liquidation.
[AI Summary]Human Data's additional pledge represents the major shareholder's personal borrowing expansion rather than funding for PeopleBio's growth, potentially worsening financial soundness and increasing governance risk. Given the current share price of 780 KRW, a further drop could lead to margin shortfalls.